Source: http://www4.law.cornell.edu/cfr/text/21/21/subpart-F
Timestamp: 2013-12-11 05:53:36
Document Index: 24722663

Matched Legal Cases: ['art 21', '§ 21', '§ 21', '§ 21', 'art 21', 'art 21', 'art 21', 'art 21']

21 CFR 21, Subpart F - Exemptions | Title 21 - Food and Drugs | Code of Federal Regulations | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter A › Part 21 › Subpart F	prev | next
21 CFR 21, Subpart F - Exemptions
There are 3 Updates appearing in the Federal Register for 21 CFR 21. Select the tab below to view, or View eCFR (GPOAccess)
§ 21.60 — Policy.
§ 21.61 — Exempt systems.
§ 21.65 — Access to records in exempt systems.
Title 21 published on 2012-04-01The following are only the Rules published in the Federal Register after the published date of Title 21.For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.2013-07-01; vol. 78 # 126 - Monday, July 1, 201378 FR 39184 - Privacy Act, Exempt Record System; Implementation
typeregulations.gov FR Doc.2013-15599 RIN Docket No.FDA-2011-N-0252 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration, Office of the Secretary Final rule. This rule is effective July 31, 2013. 21 CFR Part 21 SummaryThe Food and Drug Administration (FDA or Agency) of the Department of Health and Human Services (HHS or Department) is exempting a system of records from certain requirements of the Privacy Act to protect the integrity of FDA&apos;s scientific research misconduct proceedings and to protect the identity of confidential sources in such proceedings.
2013-01-15; vol. 78 # 10 - Tuesday, January 15, 201378 FR 2892 - Privacy Act, Exempt Record System; Withdrawal
typeregulations.gov FR Doc.2013-00723 RIN Docket No.FDA-2011-N-0252 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration, Office of the Secretary Direct final rule; withdrawal. Effective Date: The direct final rule published at 77 FR 51910, August 28, 2012, is withdrawn effective January 10, 2013. 21 CFR Part 21 SummaryThe Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) are withdrawing the direct final rule that August 28, 2012. HHS/FDA published the direct final rule to exempt scientific research misconduct proceedings records from certain requirements of the Privacy Act of 1974 in order to protect records compiled in the course of misconduct inquiries and investigations, and to safeguard the identity of confidential sources. The comment period closed on November 13, 2012. HHS/FDA is withdrawing the direct final rule because the Agency received significant adverse comment.
2012-08-28; vol. 77 # 167 - Tuesday, August 28, 201277 FR 51910 - Privacy Act, Exempt Record System
typeregulations.gov FR Doc.2012-20889 RIN Docket No.FDA-2011-N-0252 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration, Office of the Secretary Direct final rule. This rule is effective January 10, 2013. Submit either electronic or written comments by November 13, 2012. If HHS/FDA receives no significant adverse comments within the specified comment period, the Agency will publish a document confirming the effective date of the final rule in the Federal Register within 30 days after the comment period on this direct final rule ends. If timely significant adverse comments are received, the Agency will publish a document in the Federal Register withdrawing this direct final rule before its effective date. 21 CFR Part 21 SummaryThe Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) will be implementing a new system of records, 09-10-0020, “FDA Records Related to Research Misconduct Proceedings, HHS/FDA/OC.” HHS/FDA is exempting this system of records from certain requirements of the Privacy Act to protect the integrity of FDA&apos;s scientific misconduct inquiries and investigations and to protect the identity of confidential sources in such investigations. HHS/FDA is issuing a direct final rule for this action because the Agency expects that there will be no significant adverse comment on this rule.
Title 21 published on 2012-04-01The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR 21 after this date.2013-07-01; vol. 78 # 126 - Monday, July 1, 201378 FR 39184 - Privacy Act, Exempt Record System; Implementation
77 FR 51949 - Privacy Act, Exempt Record System
typeregulations.gov FR Doc.2012-20890 RIN Docket No.FDA-2011-N-0252 DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration, Office of the Secretary Proposed rule. Submit either electronic or written comments by November 13, 2012. If HHS/FDA receives any significant adverse comments, the Agency will publish a document withdrawing the direct final rule within 30 days after the comment period ends. HHS/FDA will then proceed to respond to comments under this proposed rule using the usual notice and comment procedures. 21 CFR Part 21 SummaryThe Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) will be implementing a new system of records, 09-10-0020, “FDA Records Related to Research Misconduct Proceedings, HHS/FDA/OC.” HHS/FDA proposes to exempt this system of records from certain requirements of the Privacy Act to protect the integrity of FDA&apos;s scientific misconduct inquiries and investigations and to protect the identity of confidential sources in such investigations.